Stocks · Health care · Pharmaceutical Preparations

Ultragenyx Pharmaceutical Inc.

RARE Clue Score44

United States Fiscal year ends December CIK 0001515673 Results filed 3 Nov 2026

Add to watchlist

What the insiders did Net selling

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$3.81M

$1.34M on a plan · $0.00 straight out of an exercise

Sold at will

$2.47M

13 of 28 sales

Net

−$3.81M

−$2.47M against sales at will